KMC Speciality Hospitals (India) Ltd (KMCSHIL)
Please find enclosed the Standalone Unaudited Financial Results for the Quarter and Half year ended 30th September, 2026 along with the Limited Review Report of the Statutory Auditors as ....
Press Release - Q2FY27
- Revenue 92.54 Cr and Total Income 97.97 Cr for Q2FY27
- Board approved standalone unaudited financial results for quarter and half year ended Sep 30, 2026
- Limited review report by Deloitte Haskins & Sells with no adverse remarks
- Depreciation, finance costs, and tax expenses reported with no material misstatements
- Cash flow from operations positive; investing and financing activities detailed
- No forward-looking guidance explicitly stated in filing
Source: Original filing PDF
—
view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts
BOT
🚨 KMCSHIL — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
📎 bseindia.com/xml-data/...
🎧 Audio summary ready
✓✓ 6:47 PM
Instant audio summaries2-min AI concall recap delivered with every earnings alert
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes
Add KMCSHIL to your watchlist — all of this, automated.
Sign in with Google14-day Pro trial · No credit card · Cancel anytime
More on KMC Speciality Hospitals (India) Ltd
Important.
The summary above is generated automatically from KMC Speciality Hospitals (India) Ltd's own
public regulatory filing under SEBI LODR. Indian Stock Alerts is
not a SEBI-registered Research Analyst or Investment Adviser.
This page is informational, not investment advice, a recommendation to buy
or sell any security, or any opinion about the company's business, governance
or financial health. Always read the original filing before acting and consult
a registered adviser for investment decisions.